<DOC>
	<DOC>NCT02820597</DOC>
	<brief_summary>This pilot study is a single arm study designed to evaluate the feasibility of cryoablation in the nasal passageway using the ClariFix Device, to reduce the symptoms of chronic rhinitis.</brief_summary>
	<brief_title>ClariFix Cryoablation Clinical Study</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<criteria>1. Subject is &gt;21 years of age 2. Subject has had moderate to severe symptoms of rhinorrhea and/or nasal congestion for &gt;3 months (rTNSS rating of 2 or 3) 3. Subject has signed IRBapproved informed consent form 1. Subject has clinically significant anatomic obstructions that limit access to the posterior nose including severe septal deviation, nasal polyps, and sinonasal tumor 2. Subject has a septal perforation 3. Subject has had prior sinus or nasal surgery that significantly alters the anatomy of the posterior nose 4. Subject has had prior head or neck irradiation 5. Subject has active or chronic nasal or sinus infection 6. Subject has active coagulation disorder or patient is receiving anticoagulants which cannot be safely stopped for 2 weeks 7. Subject has a history of dry nose symptoms 8. Subject is pregnant or lactating 9. Subject is participating in another clinical research study 10. Subject has an allergy or intolerance to anesthetic agent 11. Subject is an active smoker or has been a smoker within the last 6 months 12. Any physical condition that in the investigator's opinion would prevent adequate study participation or pose increased risk</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>